Ignite Creation Date:
2024-05-06 @ 10:40 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03324282
Status:
TERMINATED
Last Update Posted:
2022-05-03
First Post:
2017-10-19
Brief Title:
First-line GemcitabineCisplatin - Avelumab in Locally Advanced or Metastatic Bladder Carcinoma
Sponsor:
University Hospital Bordeaux
Organization:
University Hospital Bordeaux
Organization Data
Organization:
University Hospital Bordeaux
Class:
OTHER
Study ID:
CHUBX 201633
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Bordeaux
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None